protein 1,020 words KG: GRID1PROTEIN 2026-03-22
kind:proteinsection:proteinsstate:published
Contents

GluRδ1 (GRID1) Protein

🔬 Protein Info
Gene SymbolGRID1
Full NameGlutamate Ionotropic Receptor Delta Type Subunit 1
AliasesGRID1PROTEIN
Protein TypeReceptor
FunctionGRID1 (Glutamate Receptor Ionotropic Delta 1), also known as GluRδ1, is a member of the ionotropic glutamate receptor family.
Primary ExpressionPrefrontal Cortex, Cortex, Ventral Tegmental Area, Substantia Nigra
Subcellular Localization</strong></td><td>Postsynaptic membrane, Dendritic spines</td></tr>
PathwaysAutophagy
Ensembl IDENSG00000148677
GeneCardsGRID1
Human Protein AtlasGRID1
Dimeric AssemblyGluRδ1 forms homomeric or heteromeric assemblies, with dimerization occurring through the ATD.
Channel PropertiesUnlike AMPA or NMDA receptors, GluRδ1 forms channels with distinct conductance properties.
Splice VariantsAlternative splicing generates multiple isoforms with potentially distinct functions.
Postsynaptic ReceptorExpressed at postsynaptic densities where it contributes to synaptic transmission.
Associated Diseasesneurodegeneration
InteractionsGLUD1, LAMP1, PRKCD, CBLN1, BECN1, MAP1LC3B
KG Connections36 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (3)

Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Serine/Arginine-Rich Protein Kinase Modulation
Score: 0.42
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m
Score: 0.35

Related Analyses (6)

Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed

Related Experiments (12)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40
Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40
Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40
Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40

See Also (1)

Neurodegeneration
disease · KG edge: implicated_in